Patents by Inventor Nadine Jahchan

Nadine Jahchan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-MARCO Antibodies and Uses Thereof
    Publication number: 20240084000
    Abstract: Provided herein are anti-MARCO antibodies. Provided are also methods of generating and using anti-MARCO antibodies.
    Type: Application
    Filed: December 19, 2022
    Publication date: March 14, 2024
    Inventors: Nadine Jahchan, Michel Streuli, Xi Yang, Linda Liang, Venkataraman Sriram, Joshua Pollack, Kara Mojica, Vladislava Juric, Linnea Haeggblom, Leonard G. Presta, Sayantan Mitra
  • Anti-MARCO antibodies and uses thereof
    Patent number: 11572407
    Abstract: Provided herein are anti-MARCO antibodies. Provided are also methods of generating and using anti-MARCO antibodies.
    Type: Grant
    Filed: November 18, 2021
    Date of Patent: February 7, 2023
    Assignee: PIONYR IMMUNOTHERAPEUTICS, INC.
    Inventors: Nadine Jahchan, Michel Streuli, Xi Yang, Linda Liang, Venkataraman Sriram, Joshua Pollack, Kara Mojica, Vladislava Juric, Linnea Haeggblom, Leonard G. Presta, Sayantan Mitra
  • Anti-MARCO Antibodies and Uses Thereof
    Publication number: 20220153832
    Abstract: Provided herein are anti-MARCO antibodies. Provided are also methods of generating and using anti-MARCO antibodies.
    Type: Application
    Filed: November 18, 2021
    Publication date: May 19, 2022
    Inventors: Nadine Jahchan, Michel Streuli, Xi Yang, Linda Liang, Venkataraman Sriram, Joshua Pollack, Kara Mojica, Vladislava Juric, Linnea Haeggblom, Leonard G. Presta, Sayantan Mitra
  • METHODS OF USING ANTI-TREM2 ANTIBODIES
    Publication number: 20210317211
    Abstract: Provided herein are anti-TREM2 antibodies and related methods of making and using anti-TREM2 antibodies. Also provided are methods and compositions for enhancing an immune response and/or for the treatment of an immune-related condition in an individual, e.g., cancer, using an anti-TREM2 antibody or antigen binding fragment thereof.
    Type: Application
    Filed: June 10, 2021
    Publication date: October 14, 2021
    Inventors: Michel Streuli, Leonard G. Presta, Venkataraman Sriram, Aritra Pal, Nadine Jahchan, Mikhail Binnewies, Joshua L. Pollack, Xiaoyan Du